EarningsIBP

IBP Earnings Update

Published
Last verified by BullBD

Announcement summary

What happened
IBP published a corporate disclosure on 31 October 2021. Read the full announcement for details.
Company
Indo-Bangla Pharmaceuticals Limited
Announcement published

Original announcement

(Cont. of IBP):The Company has reported EPS of Tk. 1.18, NAV per share of Tk. 14.29 and NOCFPS of Tk. 1.33 for the year ended on June 30, 2021 as against Tk. 1.37, Tk. 13.61 and Tk. 1.54 respectively for the same period of the previous year. a. Bonus Shares and partial distribution of profit as dividend have been recommended in view to utilize its retained amount as capital for further business expansion, development of 2nd unit specially for antibiotic and cephalosporin as well as working capital.(Cont.3)

Source & verification

Source
Published company disclosure
Published through
Dhaka Stock Exchange
Announcement ID
617e101203147376ead763fe
Original publication
Last verified by BullBD
Translation
BullBD
Report incorrect information

Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.